| A Study To Evaluate ASN002 In Subjects With Atopic Dermatitis (NCT03139981) | Asana BioSciences | 2017-04-12 |
| Binimetinib in Addition to Standard Chemotherapy in KRAS Mutated NSCLC. (NCT02964689) | Swiss Cancer Institute | 2017-04-12 |
| Vinorelbine With Trastuzumab Emtansine in Pre-Treated HER2-Positive Metastatic Breast Cancer (NCT02658084) | University of Miami | 2017-04-12 |
| A Study of LY3321367 Alone or With LY3300054 in Participants With Advanced Relapsed/Refractory Solid Tumors (NCT03099109) | Eli Lilly and Company | 2017-04-12 |
| BE Study of Calcipotriene Hydrate and Betamethasone Dipropionate Topical Suspension in the Treatment of Scalp Psoriasis (NCT03122353) | Tolmar Inc. | 2017-04-11 |
| Efficacy and Safety of JMT101 in Patients With Advanced Solid Tumor (NCT04689100) | Shanghai JMT-Bio Inc. | 2017-04-11 |
| A Study of AGEN2034 in Advanced Tumors and Cervical Cancer (NCT03104699) | Agenus Inc. | 2017-04-11 |
| A Study of APR-246 in Oesophageal Cancer (NCT02999893) | Peter MacCallum Cancer Centre, Australia | 2017-04-11 |
| Alcohol Health Education With Personalized Feedback Boosters (NCT03440463) | Abby Braitman | 2017-04-11 |
| Flortaucipir PET Imaging in Subjects With FTD (NCT03040713) | Avid Radiopharmaceuticals | 2017-04-11 |
| Measuring Brain Inflammation in Autism (NCT03117530) | University of California, Los Angeles | 2017-04-11 |
| HARE-40: HPV Anti-CD40 RNA vaccinE (NCT03418480) | University of Southampton | 2017-04-11 |
| An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Melanoma Patients Receiving REGN2810 (Anti-PD-1) (NCT03002376) | Regeneron Pharmaceuticals | 2017-04-10 |
| Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability of Single and Repeat Ocular Installations (NCT03098953) | Bausch & Lomb Incorporated | 2017-04-10 |
| Study to Compare the Pharmacokinetics and Pharmacodynamics of 6 mg RGB-02 to 6 mg Neulasta (NCT03146988) | Gedeon Richter Plc. | 2017-04-10 |
| Study Assessing the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, and Pharmacokinetics of PTI-801 in Subjects With Cystic Fibrosis (NCT03140527) | Proteostasis Therapeutics, Inc. | 2017-04-10 |
| Study of the Gut Hormone Analogue Y14 in Adult Subjects (NCT03673111) | Imperial College London | 2017-04-10 |
| Ibuprofen Bioavailability Study (NCT03180879) | Reckitt Benckiser Healthcare (UK) Limited | 2017-04-10 |
| A Phase 1 Study of KHK4083 in Subjects With Atopic Dermatitis (NCT03096223) | Kyowa Kirin Co., Ltd. | 2017-04-10 |
| PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies (NCT03044743) | Yang Yang | 2017-04-07 |
| CC100: Phase 1 Multiple-Dose Safety and Tolerability in Subjects With ALS (NCT03049046) | Chemigen, LLC | 2017-04-07 |
| Dose-Optimization Trial of VXA-G1.1-NN in Healthy Volunteers (NCT03125473) | Vaxart | 2017-04-07 |
| A Study To Estimate The Effects Of Itraconazole On Pharmacokinetics Of Pf-06649751 In Healthy Adult Subjects (NCT03121664) | Pfizer | 2017-04-07 |
| CX-01 Combined With Azacitidine in the Treatment of Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia (NCT02995655) | Washington University School of Medicine | 2017-04-07 |
| Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease (NCT03077542) | National Heart, Lung, and Blood Institute (NHLBI) | 2017-04-06 |
| First-in-Human Study of KO-947 in Non-Hematological Malignancies (NCT03051035) | Kura Oncology, Inc. | 2017-04-06 |
| Study of JS001 in Patients With Advanced Neuroendocrine Tumors (NCT03167853) | Peking University | 2017-04-06 |
| Evaluating the Infectivity, Safety, and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (D46/NS2/N/ΔM2-2-HindIII) in RSV-Seronegative Infants 6 to 24 Months of Age (NCT03102034) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-04-06 |
| HUMC 1612: Optune NovoTTF-200A System (NCT03128047) | Hackensack Meridian Health | 2017-04-06 |
| Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers (NCT02830724) | National Cancer Institute (NCI) | 2017-04-06 |
| Single Ascending Dose to Study the Safety, Tolerability, PK and PD Effects of AEF0117 (NCT03325595) | Aelis Farma | 2017-04-06 |
| Safety and Efficacy of Sanaria's PfSPZ-CVac in Malian Adults (NCT02996695) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-04-06 |
| CAR T Cells in Mesothelin Expressing Cancers (NCT03054298) | University of Pennsylvania | 2017-04-06 |
| A Phase I Clinical Trial of Bevacizumab Injection (NCT05476341) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2017-04-06 |
| A Study of Sofosbuvir and Ledipasvir From Soviredia 90/400 mg Tablets (Minapharm, Egypt) Versus Harvoni 90/400 mg Tablets (Gilead Sciences, USA) (NCT04039958) | Genuine Research Center, Egypt | 2017-04-05 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ionis AGT-LRx in Healthy Volunteers (NCT03101878) | Ionis Pharmaceuticals, Inc. | 2017-04-05 |
| Delivering a Diuretic Into the Liver Artery Followed by Plugging up the Artery to Starve Out Liver Cancer Cells (NCT03107416) | Memorial Sloan Kettering Cancer Center | 2017-04-05 |
| Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Severe Impaired Renal Function (NCT02840812) | Zhejiang Medicine Co., Ltd. | 2017-04-05 |
| The Assessment of Single-Dose Safety,Tolerability, Pharmacokinetics and Pharmacodynamic of Globalagliatin Hydrochloride (NCT03171623) | Yabao Pharmaceutical Group | 2017-04-05 |
| CD19 Targeted Chimeric Antigen Receptor T Cells for B Cell Lymphoma (NCT03118180) | Zhejiang University | 2017-04-05 |
| DS-3201b for Acute Myelogenous Leukemia (AML) or Acute Lymphocytic Leukemia (ALL) (NCT03110354) | Daiichi Sankyo | 2017-04-05 |
| A Phase 1 Study to Evaluate the Effect of the Organic Anion Transporter Inhibitor Probenecid on the Pharmacokinetics of JNJ-64041575 in Healthy Adults (NCT03105986) | Janssen-Cilag International NV | 2017-04-05 |
| A Study of LY3337641 in Healthy Participants (NCT03099148) | Eli Lilly and Company | 2017-04-04 |
| Serum Opiorphin Level After Intraoperative Intravenous Lidocaine Infusion (NCT03502395) | Assiut University | 2017-04-04 |
| A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma (NCT03017820) | Mayo Clinic | 2017-04-04 |
| Evaluation of EYS606 in Patients With Non-infectious Posterior, Intermediate or Panuveitis (NCT03308045) | Eyevensys | 2017-04-04 |
| Bioequivalence Study of Vigabatrin ORPHELIA Pharma 500mg Soluble Tablets and SabrilTM 500mg Granules for Oral Administration (NCT04468282) | Orphelia Pharma | 2017-04-04 |
| A Study to Evaluate the Effect of Food on the Pharmacokinetics of TAK-831 Tablet Formulation (NCT03101293) | Neurocrine Biosciences | 2017-04-04 |
| Safety and Tolerability of TAR-302-5018 in Subjects With Idiopathic Overactive Bladder (NCT03109379) | Taris Biomedical LLC | 2017-04-04 |
| A Study to Investigate the Mass Balance of BTD-001 (NCT03107013) | Balance Therapeutics | 2017-04-03 |
| Investigation of the Impact of Smoking Status on Allergen-induced Nasal Airway Inflammation Using a Cat Hair (Felis Domesticus) Extract Nasal Allergen Challenge Model (NCT03031145) | University of North Carolina, Chapel Hill | 2017-04-03 |
| Clinical Study of TS-143 in Healthy Adult Male Subjects (Multiple-Dose Administration) (NCT03595202) | Taisho Pharmaceutical Co., Ltd. | 2017-04-03 |
| Vascular Function and Biomarker Assessments in Healthy Volunteers and in Patients With Type 2 Diabetes Mellitus (NCT04744636) | Institut de Recherches Internationales Servier | 2017-04-03 |
| Single Dose Pharmacokinetic (PK) Study (NCT03109756) | Healx AI | 2017-04-03 |
| Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism (NCT02781844) | Shire | 2017-04-03 |
| Clearance of 25-hydroxyvitamin D in Cystic Fibrosis (NCT03104855) | University of Washington | 2017-04-03 |
| Dose-dependent Effects of Oxytocin on the Amygdala and Reward System (NCT03846739) | University Hospital, Bonn | 2017-04-03 |
| Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye Syndrome (NCT03162094) | Avizorex Pharma, S.L. | 2017-04-03 |
| A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG) (NCT02924038) | Nicholas Butowski | 2017-04-03 |
| First Time in Human (FTIH) Safety and Pharmacokinetics (PK) Study of GSK3036656 in Healthy Subjects (NCT03075410) | GlaxoSmithKline | 2017-04-02 |
| Study of Safety,Efficacy and Pharmacokinetics of CT-1530 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia (NCT02981745) | Centaurus Biopharma Co., Ltd. | 2017-04-01 |
| [18F]-AZAFOL AS POSITRON EMISSION TOMOGRAPHY (PET) TRACER in FR Positive Cancer Imaging (NCT03242993) | University of Lausanne Hospitals | 2017-04-01 |
| Fecal Microbiota Transplantation for the Treatment of Obesity (NCT02741518) | Brigham and Women's Hospital | 2017-04-01 |
| Inflammatory Response In Schizophrenia (NCT03093064) | King's College London | 2017-04-01 |
| Efficacy of Buprenorphine on Postoperative Endodontic Analgesia (NCT03268278) | University Hospitals Cleveland Medical Center | 2017-04-01 |
| Green Tea With Aloe Vera Mouthwash and Chlorohexidine Mouthwash (NCT03115892) | Cairo University | 2017-04-01 |
| Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD20 (NCT03097770) | Chinese PLA General Hospital | 2017-04-01 |
| Study Evaluating the Efficacy and Safety With CAR-T Immunotherapy for CD19 Positive Lymphoma (NCT03086954) | Sinobioway Cell Therapy Co., Ltd. | 2017-04-01 |
| Dose Assessment of Melatonin in Sepsis Trial (NCT02319265) | University of Aberdeen | 2017-04-01 |
| A Trial of Topical Aloe Vera Gel in Emergency Department Patients Presenting With Simple Traumatic Wounds (NCT02819817) | NHS Lothian | 2017-04-01 |
| Individualized Antithrombotic Therapy for Patients With Ischemic Cerebrovascular Disease (NCT03471169) | Xuanwu Hospital, Beijing | 2017-04-01 |
| Platelet-Rich Plasma (PRP) Injection in Treatment of Interstitial Cystitis (NCT03104361) | Buddhist Tzu Chi General Hospital | 2017-04-01 |
| CNS10-NPC-GDNF for the Treatment of ALS (NCT02943850) | Cedars-Sinai Medical Center | 2017-04-01 |
| Phase 1/1b Study With Nab-sirolimus for Patients With Severe Pulmonary Arterial Hypertension (NCT02587325) | Aadi Bioscience, Inc. | 2017-04-01 |
| Mesenchymal Stem Cell Therapy for Type 1 Diabetes Mellitus Patients (NCT03484741) | Van Hanh General Hospital | 2017-04-01 |
| A Study of GPC3-targeted T Cells by Intratumor Injection for Advanced HCC (GPC3-CART) (NCT03130712) | Shanghai GeneChem Co., Ltd. | 2017-04-01 |
| Interleukin-21 (IL-21)- Expanded Natural Killer Cells for Induction of Acute Myeloid Leukemia (NCT02809092) | Hospital de Clinicas de Porto Alegre | 2017-04-01 |
| Adoptive Transfer of iNKT Cells for Treating Patients With Relapsed/Advanced HCC (NCT03175679) | Beijing YouAn Hospital | 2017-04-01 |
| Benzodiazepine-free Anesthetic for Reduction of Delirium (B-Free) (NCT03053869) | McMaster University | 2017-04-01 |
| Effect of Human Amniotic Epithelial Cells on Children With Spastic Cerebral Palsy (NCT03107975) | The Second Affiliated Hospital of Fujian Medical University | 2017-04-01 |
| Study of Oral Lasmiditan in Participants With Normal and Impaired Renal Function (NCT03009162) | Eli Lilly and Company | 2017-04-01 |
| Imaging With a New Agent That Finds a Cancer Protein Called HER2 (NCT03109977) | Memorial Sloan Kettering Cancer Center | 2017-03-31 |
| Tolerability and Pharmacokinetics of Toripalimab in Combination With Axitinib in Patients With Kidney Cancer and Melanoma (NCT03086174) | Shanghai Junshi Bioscience Co., Ltd. | 2017-03-31 |
| A Study to Assess the Safety and Tolerability Profile of TR399 in Healthy Volunteers and Erectile Dysfunction Patients (NCT03102398) | Tritech Biopharmaceuticals Co., Ltd. | 2017-03-31 |
| Pharmacodynamic Open-Label Trial With VXA-A1.1 Oral H1 Vaccine in Healthy Adults (NCT03121339) | Vaxart | 2017-03-31 |
| Pharmacokinetic Drug Interactions Between HGP1607 and HGP1501 (NCT03089112) | Hanmi Pharmaceutical Company Limited | 2017-03-31 |
| Japanese Bridging Study of Ivosidenib (AG-120) in Healthy Subjects (NCT03071770) | Agios Pharmaceuticals, Inc. | 2017-03-31 |
| Study of QRH-882260 Heptapeptide Application in the Colon (NCT03148119) | Danielle Kim Turgeon | 2017-03-31 |
| Comparative Bioavailability of Two Injectable Suspension Formulations of Medroxyprogesterone Acetate+Estradiol Cypionate (NCT03443089) | Galeno Desenvolvimento de Pesquisas Clínicas | 2017-03-31 |
| A Safety, Tolerability and Immunogenicity Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Tetravalent Ad26.Mos4.HIV Along With Either Clade C gp140 Plus Adjuvant OR With a Combination of Mosaic and Clade C gp140 Plus Adjuvant in Healthy HIV Uninfected Adults (NCT02935686) | Janssen Vaccines & Prevention B.V. | 2017-03-31 |
| Plasma and Intrapulmonary Concentrations Study of WCK 5222 (NCT03630094) | Wockhardt | 2017-03-31 |
| Absorption, Distribution, Metabolism and Excretion of BIA 5-1058 (NCT04991181) | Bial - Portela C S.A. | 2017-03-31 |
| Drug-drug Interaction Between Aceclofenac 200 mg and Esomeprazole 20 mg in Healthy Male Volunteers (NCT03127046) | Dong Wha Pharmaceutical Co. Ltd. | 2017-03-31 |
| Galunisertib (LY2157299) Plus Stereotactic Body Radiotherapy (SBRT) in Advanced Hepatocellular Carcinoma (HCC) (NCT02906397) | Abramson Cancer Center at Penn Medicine | 2017-03-30 |
| Short-term Metabolic Effects of Ketosteril® Supplemented Low Protein Diet in Pre-dialysis Chronic Kidney Disease (CKD) Patients (NCT03077048) | Fresenius Kabi | 2017-03-30 |
| RV001V, a RhoC Anticancer Vaccine, Against Metastasis From Solid Tumours (NCT03199872) | RhoVac APS | 2017-03-30 |
| Durvalumab in Combination With Docetaxel, Cisplatin and 5-FU for Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT02997332) | Gustave Roussy, Cancer Campus, Grand Paris | 2017-03-30 |
| A Study of Rovalpituzumab Tesirine Administered in Combination With Nivolumab and With or Without Ipilimumab for Adults With Extensive-Stage Small Cell Lung Cancer (NCT03026166) | AbbVie | 2017-03-30 |
| A Study to Assess the Pharmacokinetics of CC-122 in Subjects With Mild, Moderate, and Severe Renal Impairment (NCT03097016) | Celgene | 2017-03-30 |
| A Study of JR-141 in Patients With Mucopolysaccharidosis Type II (NCT03128593) | JCR Pharmaceuticals Co., Ltd. | 2017-03-30 |